AVR 0.90% $9.91 anteris technologies ltd

allied herpes vaccine phase i trial update, page-2

  1. 177 Posts.
    lightbulb Created with Sketch. 21
    "no safety issues raised." - tick
    "Currently there is no curative treatment for herpes and there is a major unmet medical need" - tick
    "our herpes therapeutic vaccine has huge market potential" - tick tick tick
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$9.91
Change
-0.090(0.90%)
Mkt cap ! $209.4M
Open High Low Value Volume
$10.00 $10.00 $9.65 $70.76K 7.202K

Buyers (Bids)

No. Vol. Price($)
1 300 $9.80
 

Sellers (Offers)

Price($) Vol. No.
$9.91 475 2
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.